P3 Health Partners PIII Income Statement (2021-2026)

NASDAQ PIII
$9.18 -0.23 (-2.44%)
As of: Sep 3, 2026 · 3:59 PM EDT
Reported Financials

P3 Health Partners Quarterly Income Statement

Periods 21 quarters
Latest Jun 2026

P3 Health Partners reported revenue of $386.38M and net income of $15.65M for the quarter ended Jun 2026, up 3.5% year over year. This income statement covers 21 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue
144.59M156.19M217.94M273.54M269.45M248.26M258.21M302.08M329.09M288.35M346.86M388.49M379.16M362.12M370.69M373.23M355.79M345.25M384.81M386.38M
Cost of RevenueCost of Rev
150.38M161.33M244.21M265.82M267.45M254.78M269.18M285.57M302.27M279.22M367.68M382.06M365.17M401.92M410.22M372.04M351.35M369.79M426.06M300.38M
Gross Profit
-5.79M-5.14M-26.27M7.72M2.01M-6.52M-10.96M16.51M26.82M9.13M-20.82M6.43M13.99M-39.80M-39.54M1.18M4.44M-24.54M-41.24M86.00M
Operating items
Amortization - Intangibles
21.16M
Depreciation & Amortization - TotalDep. & Amort. (Tot)
0.60M0.60M0.70M0.60M0.60M0.60M0.50M0.50M0.50M0.60M0.60M0.70M0.60M0.60M0.50M0.50M
Research & DevelopmentR&D
0.36M0.49M0.86M1.41M1.12M1.71M1.00M0.86M0.65M0.72M0.32M0.41M0.13M0.46M0.18M0.15M0.25M0.34M
Selling, General & AdministrativeSG&A
18.39M20.43M38.60M41.10M37.86M39.72M37.64M27.22M33.06M24.43M27.40M26.61M27.22M31.37M25.00M23.45M22.14M35.88M32.39M
Other Operating ExpensesOther Opex
151.81M163.38M285.65M1,138.53M268.59M752.73M311.65M321.44M287.95M385.47M404.10M382.87M441.16M13.27M385.53M365.71M366.59M0.18M312.76M
Operating ExpensesOpex
170.56M184.31M325.71M1,181.64M308.27M794.76M350.89M350.12M322.17M411.12M432.32M410.49M469.11M509.19M411.31M389.91M389.48M538.68M345.15M
Operating IncomeOp. Inc
-25.97M-28.12M-26.27M-52.17M-912.19M-60.01M-536.55M-48.82M-21.03M-33.82M-64.26M-43.83M-31.33M-106.99M-138.50M-38.09M-34.12M-44.22M-153.87M41.23M
EBIT
-25.97M-28.12M-26.27M-52.17M-912.19M-60.01M-536.55M-48.82M-21.03M-33.82M-64.26M-43.83M-31.33M-106.99M-138.50M-38.09M-34.12M-44.22M-153.87M41.23M
Non-operating items
Interest & Investment IncomeInt & Inv Inc
0.01M0.00M
Other Non Operating IncomeOther Non Op Inc.
-0.01M-0.03M0.21M2.58M0.10M-0.74M0.19M0.21M0.34M0.29M0.45M0.38M0.32M0.58M-2.16M-2.15M-0.08M
Non Operating IncomeNon Op. Inc.
-3.49M-3.93M-8.62M9.08M-5.32M6.08M-3.34M-6.32M-3.06M-3.08M-3.70M3.53M0.54M14.31M-5.08M-7.56M-25.23M-12.89M-24.31M
Net income details
EBT
-29.46M-32.05M-26.27M-60.79M-903.11M-65.33M-530.47M-52.16M-27.36M-36.88M-67.34M-47.53M-27.81M-106.45M-124.20M-43.17M-41.68M-69.45M-166.75M16.92M
Tax ProvisionsTaxes
1.86M0.29M0.23M0.41M1.77M2.07M0.97M-3.60M4.95M1.07M1.98M0.01M-1.04M1.26M
Profit After TaxPAT
-29.46M-32.05M-26.27M-60.80M-903.11M-65.33M-532.38M-52.45M-27.60M-37.30M-69.11M-49.61M-28.80M-102.90M-129.17M-44.25M-43.66M-69.50M-165.70M15.65M
Income from Non-Controlling InterestsInc. Minority
-1.96M2.80M-27.29M-50.21M-748.76M-54.16M-438.31M-43.25M-17.77M-23.99M-43.65M-30.91M-16.75M-56.34M-70.53M-23.77M-23.30M-37.87M-90.19M8.21M
Income from Continuing OperationsIncome (Continuing)
-29.46M-32.05M-26.27M-60.79M-903.11M-65.33M-532.33M-52.45M-27.58M-37.29M-69.11M-49.61M-28.77M-102.85M-129.15M-44.25M-43.66M-69.46M-165.71M15.65M
Consolidated Net IncomeConsol Net Inc.
-29.46M-32.05M-26.27M-60.79M-903.11M-65.33M-532.33M-52.45M-27.58M-37.29M-69.11M-49.61M-28.77M-102.85M-129.15M-44.25M-43.66M-69.46M-165.71M15.65M
Income towards Parent CompanyParent Net Inc
-29.46M-32.05M-26.27M-60.79M-903.11M-65.33M-532.33M-52.45M-27.58M-37.29M-69.11M-49.61M-28.77M-102.85M-129.15M-44.25M-43.66M-69.46M-165.71M15.65M
Preferred Dividend PaymentsPref Dividends
9.57M
Net Income towards Common StockholdersNet Income
-29.46M-32.05M-26.27M-10.58M-903.11M-65.33M-532.33M-52.45M-27.58M-37.29M-69.11M-49.61M-28.77M-102.85M-129.15M-44.25M-20.36M-69.46M-165.71M-2.13M
Additional items
EPS (Basic)
-0.99-0.79-0.65-0.25-21.72-1.57-12.80-1.26-0.26-0.33-0.73-0.42-0.21-0.64-0.89-13.57-6.23-21.25-50.69-0.63
EPS (Diluted)
-0.25-3.73-0.27-12.80-1.26-0.26-0.12-0.23-0.42-0.20-0.62-0.88-13.57-6.23-21.25-50.69-0.63
Shares Outstanding
29.62M40.36M40.36M41.58M41.58M41.58M41.58M41.58M107.45M114.20M94.89M118.89M136.60M161.89M145.18M3.26M3.27M3.27M3.27M3.36M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
41.58M242.05M243.04M41.58M41.58M107.45M312.68M294.59M118.89M141.08M164.70M147.00M3.26M3.27M3.27M3.27M3.36M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
29.62M40.36M41.58M41.58M41.58M41.58M243.45M312.60M313.60M313.16M315.90M357.72M357.93M358.83M7.19M7.19M7.21M7.21M7.26M
EBITDA
-25.97M-28.12M-26.27M-51.57M-911.59M-59.31M-535.95M-48.22M-20.43M-33.32M-63.76M-43.33M-30.73M-106.39M-137.80M-37.49M-33.52M-43.72M-153.37M41.23M
Interest ExpensesInt Expense
4.26M5.44M5.65M6.83M8.72M10.14M20.53M15.64M7.86M
Tax Rate
-0.35%-0.56%-0.83%-1.12%-2.62%-4.36%-3.48%3.39%-3.99%-2.49%-4.75%-0.02%0.62%7.48%